We evaluated the effect of metoprolol on the Ca2+-release through RyR2 in the CPVT hiPSC-CMs and observed that the leaky phenotype through RyR2 was not prevented properly. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.